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Alteration in the choice of DNA repair pathway with increasing
sequence selective DNA alkylation in the minor groove
Natalie Brooks 1, Peter J McHugh 1, Moses Lee 2 and John A Hartley 1
Background: Many conventional DNA alkylating anticancer drugs form adducts
in the major groove of DNA. These are known to be chie£y repaired by both
nucleotide (NER) and base (BER) excision repair in eukaryotic cells. Much less is
known about the repair pathways acting on sequence speci¢c minor groove
purine adducts, which result from a promising new class of anti-tumour agents.
Results: Benzoic acid mustards (BAMs) tethering 1^3 pyrrole units (compounds
1, 2 and 3) show increasing DNA sequence selectivity for alkylation from BAM
and 1, alkylating primarily at guanine-N7 in the major groove, to 3 which is
selective for alkylation in the minor groove at purine-N3 in the sequence
5P-TTTTGPu (Pu = guanine or adenine). This increasing sequence selectivity is
re£ected in increased toxicity in human cells. In the yeast Saccharomyces
cerevisiae, the repair of untargeted DNA adducts produced by BAM, 1 and 2
depends upon both the NER and BER pathways. In contrast, the repair of the
sequence speci¢c minor groove adducts of 3 does not involve known BER or
NER activities. In addition, neither recombination nor mismatch repair are
involved. Two disruptants from the RAD6 mutagenesis defective epistasis group
(rad6 and rad18), however, showed increased sensitivity to 3. In particular, the
rad18 mutant was over three orders of magnitude more sensitive to 3 compared
to its isogenic parent, and 3 was highly mutagenic in the absence of RAD18.
Elimination of the sequence speci¢c DNA adducts formed by 3 was observed in
the wild type strain, but these lesions persisted in the rad18 mutant.
Conclusions: We have demonstrated that the repair of DNA adducts produced
by the highly sequence speci¢c minor groove alkylating agent 3 involves an error
free adduct elimination pathway dependent on the Rad18 protein. This represents
the ¢rst systematic analysis of the cellular pathways which modulate sensitivity to
this new class of DNA sequence speci¢c drugs, and indicates that the enhanced
cytotoxicity of certain sequence speci¢c minor groove adducts in DNA is the result
of evasion of the common excision repair pathways.
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Introduction
An important class of anticancer agents that bind and al-
kylate in the minor groove of DNA are currently under
investigation. These include analogues of naturally occur-
ring compounds such as CC-1065 [1], calicheamycin [2],
the pyrrolo[2,1-c][1,4]benzodiazepines [3] and distamycin
[4] (Figure 1). We have previously evaluated a series of
benzoic acid mustard (BAM)-tethered oligopyrrole ana-
logues of distamycin for their cytotoxicity, cross-linking
ability and sequence speci¢city [5,6]. They consist of one
(1), two (2) and three (3) pyrrole-amide units tethered to
BAM (Figure 1). These analogues were shown to be more
cytotoxic than BAM itself, with cytotoxicity increasing as
the number of pyrrole units increased. Compound 1 pro-
duced guanine-N7 alkylations in the major groove of DNA
comparable to the pattern shown by BAM itself, as well as
alkylations at some adenine-N3 sites in the minor groove.
However, 2 and 3 did not produce detectable guanine-N7
alkylations but alkylated solely within AT tracts. Further-
more, 3 preferentially alkylated at only two sequences, 5P-
TTTTGG and 5P-TTTTGA (con¢rmed as guanine-N3
and adenine-N3 lesions at the underlined bases, respec-
tively), in preference to other sites, including 5P-TTTTAA.
Hence, the most cytotoxic drug of the series possessed the
most enhanced sequence speci¢city for alkylation [6]. Tal-
limustine, a compound of very similar structure to 3 and an
identical pattern of sequence speci¢c alkylation, has re-
cently shown activity as an anticancer agent in both phase
I and II clinical trials [7,8].
Organisms possess numerous and complex mechanisms
that function in maintaining the integrity of their genetic
material. These pathways are involved in the removal and
tolerance of DNA damage caused by both endogenous and
exogenous sources, including the damage produced by a
variety of clinically used anticancer drugs. The budding
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yeast, Saccharomyces cerevisiae, has been shown to be a ro-
bust model system for repair in human cells [9,10].
Two major systems of excision repair, base (BER) and nu-
cleotide (NER), have been identi¢ed [10]. BER facilitates
the repair of damaged bases through a sequence of enzyme
reactions, the ¢rst of which involves cleavage of the N-
glycosyl bond of the damaged base by speci¢c DNA gly-
cosylases [11]. The apurinic/apyrimidinic site created is
excised by a separate apurinic endonuclease or by an apur-
inic lyase function inherent to the glycosylase and the gap
¢lled. NER involves the ATP-dependent excision of bulky
DNA damage, for example, UV pyrimidine dimers and
cisplatin-induced intrastrand cross-links, in the form of a
lesion-containing oligonucleotide by a multi-enzyme com-
plex [12]. The yeast RAD3 epistasis group includes RAD1,
RAD2, RAD3, RAD4, RAD10, RAD14, RAD25, RAD7,
RAD16 and RAD23 genes. The ¢rst seven genes are essen-
tial for NER, and loss of function mutants are totally de-
fective in the incision step of NER.
Double-strand breaks (DSBs) and single-strand gaps play a
critical role in the initiation of homologous recombination
[13] and DSBs may also be repaired by non-homologous
end-joining (NHEJ; [14]) in both yeast and mammalian
cells. Homologous recombination at DSBs and gaps abso-
lutely requires the activity of the Rad52 protein [13,15]. In
yeast, the Ku proteins (Yku70 and Yku80) direct DSBs into
NHEJ which is independent of terminal DNA sequence
homology [16].
In addition to an important role in maintaining genomic
stability, the mismatch repair (MMR) system is known to
in£uence the capacity of cells to repair DNA^anticancer
drug adducts. Mutations in the MMR genes MLH1,
MLH2, MSH2, MSH3 and MSH6 have been shown to re-
sult in resistance to cisplatin, carboplatin and doxorubicin
[17,18], and a mutation in the yeast MSH5 gene resistance
to the DNA methylating agent N-methyl-NP-nitro-N-nitro-
soguanidine [19].
Figure 1. Structures of distamycin and
oligopyrrole analogues of distamycin
tethered to BAM (1, 2 and 3).
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Finally, the RAD6 DNA repair epistasis group is the most
complex, because it represents several repair sub-path-
ways: an error free tolerance pathway and a mutagenic
pathway [20], as well as proteins involved in cell cycle
checkpoints [21]. Previous studies have shown that muta-
tions in the RAD6 and RAD18 genes of this group have
prominent effects on sensitivity to a diverse variety of
DNA damaging agents, such as UV, Q-rays and alkylating
agents [9]. It has been demonstrated that whereas Rad6
has no af¢nity for DNA, Rad18 binds single-stranded
DNA. Therefore, it has been suggested that association
of Rad6 with Rad18 provides a means of targeting Rad6
to DNA regions containing damage, at which point the
ubiquitination activity of Rad6 modulates downstream
DNA repair and tolerance mechanisms [22].
Our previous studies have shown that the repair of conven-
tional nitrogen mustard-induced N-alkyl purines in the ma-
jor groove of DNA (at guanine-N7) involves BER and
NER in S. cerevisiae [23]. However, very little is known
about the repair mechanisms for complex agents that
bind in the DNA minor groove. In order to gain a better
understanding of the repair of damage produced by minor
groove alkylating agents, we have investigated the role of
BER, NER, MMR, recombination, NHEJ and mutagene-
sis prone activities in the repair of DNA adducts formed by
1, 2 and 3 in the model eukaryote S. cerevisiae and dem-
onstrated a pivotal role for the RAD18 product in the repair
of targeted minor groove adducts.
Results
NER, BER and recombination mutants are hypersensitive
to compounds 1 and 2, but not 3
We employed S. cerevisiae strains totally de¢cient in specif-
ic DNA repair pathways (Table 1) in order to delineate the
mechanisms involved in the elimination of DNA adducts
produced by compounds 1, 2 and 3 (Figure 1). Survival
studies were used as a screen to determine the involve-
ment of speci¢c pathways in the elimination of DNA ad-
ducts. Survival curves were constructed and LD50 values
(the dose of compound required to reduce survival by
50%) were calculated (Figure 2, Table 2). Reduction in
survival by 50% was not observed with any of the com-
pounds in the parental repair pro¢cient strains, DBY747,
W303-1A and W303-1B, at the highest dose employed (1
mM). The BER mutant, mag1, defective in 3-methylade-
nine DNA glycosylase activity, only showed increased sen-
sitivity to 1, whereas the ogg1 strain, defective in formimi-
dopyrimidine DNA glycosylase (Fapy DNA glycosylase)
and 8-oxoguanine glycosylase, possessed increased sensi-
tivity to both 1 and 2. None of the BER mutants showed
any sensitivity to 3 at concentrations up to 1 mM.
The rad4 (NER) mutant showed comparable sensitivity to
1 and 2, however, another NER disruptant rad14 was only
sensitive to 2 at concentrations up to 1 mM. The rad4
mag1 double mutant, de¢cient in NER and 3-methylade-
nine DNA glycosylase activity, possessed comparable sen-
sitivity to the mag1 single mutant for 1. A synergistic effect
on sensitivity in this double mutant was however observed
for 2 compared to the single mutants alone. Again, no
sensitivity to 3 was shown in any BER or NER repair
de¢cient single or double mutants up to 1 mM.
Since none of the BER, NER or excision repair double
mutants was found to be sensitive to 3 at the highest con-
centration employed, we explored possible roles for other
mechanisms of DNA repair and damage tolerance such as
recombination, NHEJ, MMR and post-replicative repair.
The homologous recombination mutant, rad52, showed
Table 1
S. cerevisiae strains used in this study.
Strain Genotype Source Reference
DBY747 MATK his3-v1 leu2-3, 112 trp1-289 ura3-52 W. Xiao [26]
WXY 9394 DBY747 with rad4v::hisG-URA3-hisG W. Xiao [26]
LP14v DBY747 with rad14v::URA3 R. Waters [37]
WXY 9345 DBY747 with rad4v::hisG-URA3-hisG and mag1v::hisG W. Xiao [26]
JC 8901 DBY747 with mag1::hisG-URA3-hisG L. Samson [36]
WXY 9387 DBY747 with rad52v::LEU2 W. Xiao [26]
WXY 9382 DBY747 with rev3v::LEU2 W. Xiao [26]
WXY 9326 DBY747 with rad18v::TRP1 W. Xiao [26]
WXY 9376 DBY747 with rad6v::LEU2 W. Xiao [26]
rev3 rad18 DBY747 with rev3v::LEU2 rad18v::TRP1 W. Xiao ^
W303-1A MATK ade2-1 his3-11 leu2-15 trp1-1 ura3-3 can1-100 S. Boiteux [38]
W303-1B MATK ade2-1 his3-11 leu2-15 trp1-1 ura3-3 can1-100 S. Boiteux [38]
CD132 W303-1A with ogg1v::TRP1 S. Boiteux [38]
yku70 W303-1B with yku70::URA3 S. Jackson ^
JDY 2 W303-1B with yku70::leu2 and rad52::TRP1 S. Jackson ^
WT-B MATK trp1-h3 his4-cla leu2-r met13-4 lys2-d ade1 ura3 cyhr canS R. Brown [17]
RBT 311 WT-B with pms1::LEU2 R. Brown [17]
RBT 289 WT-B with msh2::LEU2 R. Brown [17]
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some increased sensitivity to 1 and greater sensitivity to 2,
whereas the mutant defective in NHEJ, yku70, only
showed increased sensitivity to 1 at up to 1 mM. A double
mutant, yku70 rad52, was sensitive to 1 and 2, but the level
of sensitivity of the double mutant was comparable to the
rad52 mutant alone for both 1 and 2. No increased sensi-
tivity was observed to 3 in any of the recombination and
NHEJ de¢cient mutants at the highest concentration used.
The parent (WT-B) and pms1 MMR mutants were slightly
sensitive to 1, however, decreased sensitivity to 1 was seen
in the msh2 repair mutant. These MMR mutants showed
sensitivity equivalent to the parent for 2 and 3.
The RAD6 and RAD18 genes are important determinants
of cellular sensitivity to 3
Of the RAD6 epistasis group, involved in post-replication
repair and mutagenesis, a rev3 strain, de¢cient in a subunit
of the mutagenic DNA polymerase j, possessed a small
increased sensitivity to 1 and 2, but not to 3 at up to
1 mM. The rad6 mutant was equally sensitive to 1 and 2
and was one of only two tested mutant strains that showed
any increased sensitivity to 3, although the level of sensi-
tivity was less than that observed for 1 and 2. In contrast,
Figure 2. Sensitivity of BER, NER, recombination, MMR, post-
replication repair and mutagenesis mutants to (A) compound 1,
(B) compound 2 and (C) compound 3. Bars are colour-coded:
blue represents NER and BER mutants and their repair pro¢cient
parental strains (DBY747, and W303-1A for ogg1), red
recombination and NHEJ mutants (parent W303-1B), green
mismatch mutants (parent WT-B) and yellow members of the
RAD6 epistasis group (parent DBY747). Results are the mean
LD50 of at least three independent experiments, error bars show
standard error of the mean.
6
Table 2




DBY747 s 1000 s1000 s 1000
W303-1A s 1000 s1000 s 1000
ogg1 211 þ 55 237 þ 54 s 1000
mag1 287 þ 71 s1000 s 1000
rad4 492 þ 444 503 þ 432 s 1000
rad4 mag1 203 þ 82 35 þ 2.3 s 1000
rad14 s 1000 350 þ 44 s 1000
W303-1B s 1000 s1000 s 1000
rad52 440 þ 14.1 97 þ 17 s 1000
yku70 491 þ 313 s1000 s 1000
yku70 rad52 348 þ 266 116 þ 84 s 1000
WT-B 616 þ 380 s1000 s 1000
pms1 270 þ 200 s1000 s 1000
msh2 s 1000 s1000 s 1000
rev3 717 þ 25 900 þ 173 s 1000
rad6 189 þ 155 181 þ 60 600 þ 300
rad18 335 þ 23 17 þ 1 0.7 þ 0.4
rev3 rad18 263 þ 240 6 þ 5 4 þ 1.2
Results are the mean of at least three experiments. Errors are the
standard error of the mean.
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the rad18 mutant was extremely sensitive to compound 3
by over three orders of magnitude. This strain was also the
most sensitive to 2 of any of the strains tested but at least
20-fold less than for 3. Only a moderate increased sensi-
tivity was observed for 1 in the rad18 strain, which was of a
level seen with several other mutants. The order of sensi-
tivity in the rad18 mutant to 1, 2 and 3 was the same as
that observed previously in human tumour cells [5]. The
rev3 rad18 double mutant demonstrated equivalent sensi-
tivity to the rad18 single mutant for 1, 2 and 3.
Compound 3 is mutagenic in a rad18 mutant
The mutagenic potential of 3 was assessed in the rad18,
rev3, rev3 rad18 and isogenic parent (DBY747) strains using
the L-canavanine resistance forward mutation assay. The
conventional non-targeted nitrogen mustard mechloreth-
amine (HN2) was also included in this experiment as a
positive control since it is an established mutagen in this
test [23]. These data show (Figure 3) that 3 was not muta-
genic in the repair pro¢cient, parental yeast strain DBY747
or, as expected, a rev3 strain. However, 3 was highly mu-
tagenic in the rad18 strain (Figure 3). This mutagenesis
was eliminated in the rev3 rad18 double mutant. The mu-
tagenic potential of HN2 was con¢rmed in the DBY747
(Figure 3).
The DNA adducts formed by compound 3 are not
eliminated in the rad18 strain
Since compound 3 gave no signi¢cant cytotoxicity in the
majority of the yeast strains tested, the possibility that this
compound did not reach its cellular target had to be elim-
inated. The single-strand ligation polymerase chain reac-
tion (sslig-PCR) method was used to follow the induction
and repair of the DNA damage at the nucleotide level in
cells, in order to clearly establish that 3 is able to enter the
yeast cells, that it hits the same sequence speci¢c DNA
target in vivo and in vitro, and to investigate whether the
Rad18-mediated pathway involves elimination or only tol-
erance of the DNA adducts. The repair capacity of the
highly sensitive rad18 mutant compared to its isogenic par-
ent DBY747 was assessed using primers speci¢c for the
Figure 3. Compound 3-induced forward mutation frequency in the
ARG1 gene. Parental (DBY747), rev3, rad18 and rev3 rad18
mutants were treated with stated doses of compound 3 for 5 h at
28³C. Aliquots containing 2U106 cells were plated out onto SC-
arg plates supplemented with L-canavanine and scored after 5^6
days growth at 28³C. Values calculated by scoring the fraction of
canavanine resistant colonies arising per 108 survivors where
survival was simultaneously measured. Open squares, DBY747;
closed square, rev3 mutant; closed circle, rad18 mutant; open
triangle, rev3 rad18; and closed triangle, DBY747 treated with
HN2. Results are the mean of two independent experiments.
Figure 4. sslig-PCR of DNA extracted from a parental (DBY747)
strain and a rad18 disruptant. Lane C, control untreated genomic
DNA; lane T, genomic DNA treated with 3 (10 WM) for 5 h at
28³C; lane U, DNA from control untreated DBY747 or rad18
mutant cells; lanes represented by 0 min, DNA extracted from
DBY747 or rad18 mutant cells after 5 h treatment at 28³C with
3 (250 WM); lanes represented by 120 min, DBY747 or rad18
cells resuspended in YEPD medium and DNA extracted following
120 min post-treatment incubation.
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transcribed strand of the MFA2 gene (Figure 4). Lanes C
and T represent untreated puri¢ed genomic DNA and the
same DNA treated in vitro with 3 (10 WM) for 5 h, respec-
tively. There are several prominent sites of DNA adduct
formation along the length of the MFA2 gene, shown by
the arrows, corresponding to adducts at 5P-TAATAA, 5P-
AAATTA with two major sites at 5P-AGTTTG and 5P-
ATTTGA (Figure 4). Note that the DNA sequence ana-
lysed does not contain the most preferred 5P-TTTTGG or
5P-TTTTGA sequences [6]. In DBY747 and rad18 cells
treated with 250 WM 3 for 5 h (lanes 0, Figure 4), the
DNA damage sites in both strains are comparable to those
seen in genomic DNA treated with 3 (lane T, Figure 4).
Following removal of drug and further incubation of cells
in rich media for 120 min, near-complete removal of the
damage is observed in the parental DBY747 strain. Indeed
additional experiments (not shown) indicate that signi¢cant
repair occurs within the ¢rst 30 min of post-treatment in-
cubation in this strain. In contrast, in the rad18 mutant
(Figure 4) or the rad18 rev3 strain (not shown), the damage
is still clearly evident after 120 min post-treatment incuba-
tion. Since it is possible that the decrease in adducts ob-
served is the result of cell growth in DBY747, rather than
elimination of adducts, it was necessary to be certain that
no cell division occurred during the drug treatment, or
subsequent post-treatment incubation. No growth was ob-
served in either DBY747 or the rad18 strain during this
period (data not shown), since it appears that following
5 h incubation in phosphate-buffered saline (PBS), even
in the absence of drug, the cells are arrested for at least a
further 120 min.
Discussion
We have determined the DNA repair mechanisms in-
volved in the elimination of the DNA adducts produced
by the oligopyrrole compounds 1, 2 and 3, and a model
summarising our ¢ndings is presented in Figure 5 and
discussed below.
Figure 5. Model for the repair pathways
acting on the DNA adducts produced by
1 (A), 2 (B) and 3 (C). The adducts
produced by 1 at purines in the major
groove are repaired by both NER and
BER, and the bold arrow indicates that
BER dominates over NER. The adducts
produced by 2 in the minor groove with
limited sequence selectivity are good
substrates for both BER and NER. In
contrast, the adducts produced by 3 with
strong sequence speci¢city at purine-N3 in
the minor groove are not repaired by NER
or known BER activities, but an error free
process requiring Rad18 and involving
Rad6 is instead employed. Note that the
damaged DNA may have to be single-
stranded prior to Rad18 binding.
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The yeast strains de¢cient in BER, NER, MMR and re-
combination possessed no increased sensitivity over their
isogenic parent to 3 at the highest dose used, even though
the expected sequence speci¢c minor groove adducts are
readily formed in the DNA of yeast cells as demonstrated
by sslig-PCR. This suggests that the cytotoxic DNA ad-
ducts formed by 3 are not processed by these repair path-
ways. In contrast, the increased sensitivity to 1 in the 3-
methyladenine DNA glycosylase mutant, mag1, over wild
type suggests that the DNA adducts formed by 1 are rec-
ognised and removed by this enzyme in vivo. These data
are consistent with Escherichia coli BER (AlkA protein) data
both in vitro and in vivo [24]. Several studies have recently
revealed the structural basis of the activity of 3-methyl-
adenine glycosylase proteins, which are enzymes with a
extraordinarily broad substrate speci¢city for damaged
bases [25].
Compound 1 was previously shown to alkylate guanine
bases at the N7 position with a pattern comparable to
that shown by BAM [6]. These adducts may also be re-
moved by the Fapy DNA glycosylase enzyme since an
increase in sensitivity is observed in the Fapy DNA gly-
cosylase mutant, ogg1, over its isogenic parent W303-1A.
Although 2 does not alkylate at guanine-N7, it does alky-
late at adenine-N3 in the minor groove [6]. These obser-
vations are consistent with previous work that has found
that some adenine-N3 and guanine-N3 adducts are sub-
strates for the Fapy DNA glycosylase [11]. The present
study suggests that 3-methyladenine and Fapy DNA gly-
cosylases can act on adducts from 1, which are primarily
purine-N7, only Fapy DNA glycosylase can act on adducts
from 2, which are exclusively purine-N3, and neither gly-
cosylases act on the highly sequence speci¢c but bulkier
minor groove purine-N3 adducts produced by 3.
We have recently examined the excision repair of untar-
geted nitrogen mustard N-alkyl purine adducts in S. cerevi-
siae [23] in detail and have con¢rmed the involvement of
both NER and BER (speci¢cally the 3-methyladenine
DNA glycosylase). In the present study, the sensitivity of
the rad4 mag1 strain was primarily the result of the Mag1
defect since the sensitivity of this double mutant was not
signi¢cantly greater than that of the mag1 single mutant,
and the rad4 single mutant was rather less sensitive. Fur-
ther, the ogg1 strain was even more sensitive than the rad4
mag1 strain, indicating that Fapy glycosylase activity is also
important in eliminating the adducts formed by 1. Taken
together, this indicates that BER is more important than
NER for the elimination of these untargeted major groove
adducts, which signi¢cantly differs from observations made
with nitrogen mustard where NER clearly dominates over
BER [23].
In contrast, a synergistic effect is observed in the rad4
mag1 double mutant, with an increased sensitivity over
the single mutants for 2 of over 29-fold (mag1) and 14-
fold (rad4). Therefore, both BER and NER appear to be
involved as overlapping repair pathways for the adducts
formed by 2. Along with bulky adduct removal, it is known
that bases modi¢ed by monofunctional alkylating agents
are substrates for NER [26,27]. These agents produce ad-
ducts which cause only minor helical distortions, for exam-
ple, methyl methanesulfonate (MMS). The synergistic sen-
sitivity seen in the double repair mutant, rad4 mag1,
suggests that NER (rad4) and BER (mag1) pathways com-
pete for the same lesions caused by 2. In addition, we have
ruled out any functional redundancy between the NER
and Fapy glycosylase activities in the repair of adducts
produced by 3 since the sensitivity of a rad14 ogg1 double
disruptant is the same as its isogenic parent W303-1A (re-
sults not shown).
Mutations in RAD52 and yku genes result in sensitivity to
agents that produce DSB and are only minimally sensitive
to agents that generate other types of DNA lesions. The
data obtained in this study suggest that adducts formed by
2 are more readily repaired by homologous recombination
compared to compound 1 adducts. Furthermore, both ho-
mologous recombination and NHEJ may play a prominent
role in the repair of adducts produced by 1 but not 2. This
is demonstrated by the comparable sensitivity observed for
2 in the double repair mutant, yku70 rad52, compared to
rad52 alone. Eliminating homologous recombination may
result in accumulation of DSB and single-strand gaps, par-
ticularly in replicating cells during the repair of 1 and 2.
MMR is not involved in the repair of adducts produced by
2 or 3. However, the data indicate that inactivation of the
MMR gene, msh2 (but not the pms1 gene), results in de-
creased sensitivity to 1. Decreased sensitivity in the MMR
mutants treated with the anticancer drugs cisplatin, carbo-
platin and doxorubicin was also observed previously by
Durant et al. [17] and was of similar magnitude. The au-
thors have postulated that MMR proteins, in addition to
their role in mismatch recognition, decrease adduct toler-
ance during DNA replication by modulating levels of re-
combination-dependent bypass and NER [17]. Tolerance
is, therefore, enhanced upon removal of MMR proteins
resulting in decreased sensitivity to anticancer agents [18].
Sensitivity to 3, at less than 1 mM, was only observed in
the RAD6 epistasis group involved in error free and error
prone tolerance pathways. The rad6 and rad18 mutants are
defective in both error free and error prone tolerance path-
ways and mutagenesis, the rev3 mutant affects only the
mutagenesis pathway, and the mms2 mutant was recently
shown to display defective error free post-replication repair
parallel to the rev3 mutagenesis pathway [20]. In particular
the rad18 mutant was highly sensitive to compound 3. The
function of the Rad18 protein has not yet been clearly
de¢ned, but signi¢cantly it appears to bind to single-
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stranded DNA at runs of poly dT [28]. The sites of pre-
ferred alkylation for 3, i.e. at 5P-TTTTGG and 5P-
TTTTGA, contain poly dT stretches [6]. We can speculate
that the Rad18 protein upon binding to the single-stranded
DNA may provide access to the DNA adduct and perhaps
recruit the Rad6 protein, thus allowing further proteins to
repair or tolerate adducts formed by 3. However, these
results are novel since the literature indicates that isogenic
rad6 and rad18 strains normally demonstrate very similar
(and epistatic) hypersensitivity to DNA damaging agents
[29]. Indeed the rad6 and rad18 strains used here have
been shown to exhibit equivalent levels of hypersensitivity
to cisplatin, nitrogen mustard and MMS (P.J.M., unpub-
lished results, and [26]). In addition, since rad6 strains
are known to readily accumulate suppressor mutations in
the SRS2 gene [30] which might obscure the real drug
sensitivity of the strain, care was taken to avoid the accu-
mulation of these mutations and only slow-growing rad6
cultures were used in experiments, and the strain was reg-
ularly independently shown to demonstrate the expected
level of hypersensitivity to nitrogen mustard and cisplatin.
While rad6 null mutants display phenotypic defects sepa-
rate from those involved in the DNA damage response, for
example defects in telomere-associated gene silencing [31]
and N-end rule protein degradation [32], we are not aware
of any studies where a rad18 strain demonstrates a much
more severe repair phenotype than its isogenic rad6 rela-
tive. This suggests that the Rad18 protein might be play-
ing a role additional to the Rad6-mediated pathway out-
lined above; perhaps Rad18 recruits other repair factors to
the site of the adducts produced by 3 in addition to Rad6.
We would further postulate that human cells, which are
much more sensitive to 3 than repair pro¢cient yeast cells
[6], are perhaps de¢cient either in an equivalent Rad18
activity or in the factors acting downstream from this, as-
suming that the level of DNA damage incurred is similar.
Previous studies have shown that mutagenesis by both
mono- and bifunctional alkylating agents is responsible
for the carcinogenic side effects of treatment with these
agents [33]. Therefore, the mutation frequency of 3 was
determined using the canavanine forward mutation assay.
Measurements of forward mutation frequency (cans to
canr) indicate that mutagenic events are substantially in-
duced by 3 in rad18 cells, but not in the parental strain
DBY747 or the rev3 strain. This demonstrates that error
free Rad18-dependent processes are involved in the re-
moval or tolerance of adducts produced by 3. By perform-
ing sslig-PCR, we have established that adducts formed by
3 are excised from the DNA and not simply tolerated.
Since excision of the adducts produced by 3 is absent in
the rad18 mutant, the adducts must be tolerated via an
error prone pathway accounting for the high level of in-
duced mutagenesis in this strain. This error prone pathway
was clearly shown to be that controlled by Rev3 (polymer-
ase j) since the strong mutagenic effect of 3 on the rad18
strain was eliminated in the rad18 rev3 double mutant.
Signi¢cance
There is currently considerable interest in the use of se-
quence speci¢c DNA binding molecules as anti-tumour
drugs. It appears that greater sequence speci¢city, com-
bined with a preference for the minor groove, enhances
the cytotoxicity of such agents. One possible explanation
for this is that the DNA adducts produced evade those
DNA excision repair pathways which ef¢ciently act on
the bulky drug adducts produced in the major groove by
conventional nitrogen mustards and cisplatin. We have sys-
tematically compared the DNA repair pathways acting on a
family of non-targeted major groove binding and targeted
minor groove binding oligopyrrole analogues of distamycin
tethering BAM. The yeast S. cerevisiae was chosen as the
experimental model since strains with disruptions of all the
known major eukaryotic DNA repair pathways are avail-
able. Screening a library of strains for drug sensitivity in-
dicated that the non-targeted major groove binding adducts
are repaired by a combination of NER and BER, as we
have previously demonstrated for nitrogen mustard. In
sharp contrast, the sequence speci¢c minor groove adducts
produced by a targeted molecule are not substrates for
these pathways. Using PCR-based techniques to follow
the induction and repair of the minor groove DNA adducts
at nucleotide resolution in intact cells, we demonstrated
that they are rapidly eliminated in repair competent cells.
A rad18 disruptant, however, is extraordinarily sensitive to
this drug, and is unable to eliminate the adducts. We pro-
pose that the Rad18 protein is able to recognise the minor
groove adducts, and then recruit further repair factors re-
quired to eliminate the adducts.
These observations support the idea that the enhanced
cytotoxicity of some minor groove sequence speci¢c
DNA adducts is the result of evasion of the common ex-
cision repair pathways, and repair is instead dependent on
Rad18 as a damage sensor prior to adduct elimination.
Clearly an appreciation of the repair pathways which mod-
ulate the sensitivity of cells, both normal and tumour, to
such drugs is central to their development as novel thera-
pies. In addition, there is the exciting possibility of devel-
oping dual therapies consisting of agents which interfere
with relevant repair pathways and potentiate the ef¢cacy of
speci¢c DNA damaging drugs.
Materials and methods
Materials
The synthesis and characterisation of the BAM conjugates (Figure 1)
has been reported previously [5]. Compounds 1, 2 and 3 were prepared
as 100 mM stocks in DMSO/1% HCl.
Yeast strains
The S. cerevisiae haploid strains employed, their genotypes and source
are listed in Table 1.
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Yeast survival curves
For S. cerevisiae cytotoxicity curves, a single colony picked from a
YEPD plate from the appropriate yeast strain was grown overnight to
exponential phase (12^16 h) in YEPD [34] medium at 28³C. The density
of the yeast cultures was determined by counting with a haemocytom-
eter. Cells were pelleted at 500Ug, 10 min, 20³C and adjusted to a ¢nal
density of 2U107 cells/ml in cold PBS. Cells were then treated with test
agent for 5 h at 28³C in a orbital incubator. After drug treatment, 2U107
cells were washed twice in PBS solution and resuspended in a ¢nal
volume of 1 ml. Subsequent dilutions of the stock cell suspension
were made and plated onto YEPD/agar plates at a density of 200 col-
onies per plate. The number of yeast colonies per plate was scored after
3 days incubation at 28³C.
L-Canavanine resistance forward mutation assay
A single colony from the appropriate yeast strain was grown overnight
(as described above) and resuspended at a ¢nal concentration of
2U107 cells/ml in PBS. Cells were then treated with test agent for 5 h
at 28³C. After drug treatment, the cells were washed twice and 2U107
cells resuspended in a ¢nal volume of 1 ml in PBS. From this stock
suspension of cells, 100 Wl cells (2U106 cells) were plated onto CSM
3arg+can plates (1.7% agar, 0.67% yeast nitrogen base without amino
acids, 2% glucose; Sigma, UK, and 0.074% complete supplement mix-
ture minus arginine (Bio 101, UK) supplemented with 60 Wg/ml L-cana-
vanine, pH 6.5). The number of yeast colonies per plate was scored
after 5^6 days incubation at 28³C.
Oligonucleotide primers
For the MFA2 gene transcribed strand: 2.5B 5P-biotin CAT TGA CAT
CAC TAG-3P; 2.5C 5P-AGA CAC CAG CGA GCT ATC AT-3P; 2.5D 5P-
AGC GAG CTA TCA TCT TCA TAC AA-3P. Ligation oligonucleotide: 5P-
ATC GTA GAT CAT GCA TAG TCA TA-3P. Ligation primer: 5P-TAT
GAC TAT GCA TGA TCT ACG AT-3P.
sslig-PCR [35]
A single colony from the appropriate yeast strain was grown overnight,
as described above. Cells were counted, centrifuged and resuspended
at a concentration of 3U107 cells/ml in PBS. Cells were treated with test
agent for 5 h at 28³C. After drug treatment, cells were washed twice, 10
ml of cells was removed for time 0 min sample and the remaining 20 ml
was resuspended in YEPD medium and incubated at 28³C for 60 and
120 min. After this post-treatment incubation, the cells were centrifuged
at 500Ug for 10 min at 20³C. Genomic DNA was puri¢ed using a
Nucleon kit for yeast DNA extraction (Nucleon Biosciences, UK). The
genomic DNA was then cut with 10 U of RsaI overnight in 1UOne-Phor-
All buffer (Pharmacia, UK). The DNA was precipitated and the DNA
concentration determined £uorometrically.
First round primer extension was carried out, in a volume of 40 Wl, using
0.02 Wg digested DNA. The PCR was carried out using 0.6 pmol of 5P-
biotinylated primer B and the reaction mixture composed of 20 mM
(NH4)2SO4, 75 mM Tris^HCl pH 9.0, 0.01% (w/v) Tween 20, 4 mM
MgCl2, 0.2% gelatin, 250 WM each dNTP and 1 U Taq polymerase.
The DNA was initially denatured at 94³C for 4 min and then subjected
to 30 cycles of 94³C, 1 min, 51³C, 1 min, 72³C, 1 min+1 s extension/
cycle on a PT-100 thermal cycler with a hot bonnet (MJ Research,
USA). The mixture was subjected to a ¢nal extension at 72³C for
5 min and then cooled to 4³C. To capture and purify the products of
biotinylated primer extension the PCR mixture, 10 Wl of 5Uwashing and
binding buffer (5 mM Tris^HCl pH 7.5, 1 mM EDTA, 1 M NaCl) was
added, followed by 5 Wl washed streptavidin M-280 Dynabeads (Dynal,
UK). The suspension was incubated for 30 min at 37³C with occasional
agitation. The beads were sedimented in a magnetic rack and washed
three times with 200 Wl 10 mM TE (pH 7.6). The beads were resus-
pended in 10 Wl ligation mixture containing 10UT4 RNA ligase buffer
(including 1 mM hexammine cobalt III chloride), 50% PEG 8000, 20
pmol ligation oligonucleotide and 20 U T4 RNA ligase, and ligated over-
night at 22³C. The ligation oligonucleotide was supplied with a 5P-phos-
phate, essential for ligation, and a 3P-terminal amine which blocks its
self-ligation. After ligation, the beads were washed three times with 200
Wl TE pH 7.6 and resuspended in 40 Wl ddH2O for the second round
PCR. The second round PCR mixture, the volume of which was 100 Wl,
contained 10 pmol of each primer C and ligation primer that was com-
plementary to the ligated oligonucleotide. The buffer composition was as
for the ¢rst round PCR except that 2.5 U of Taq polymerase was used.
The cycling conditions were: an initial denaturation at 94³C for 4 min,
then 18 cycles of 94³C, 1 min, 58³C, 1 min, 72³C, 1 min+1 s extension/
cycle. The mixture was ¢nally incubated at 72³C for 5 min and cooled to
4³C for 1 h. The third round was carried out by adding 10 Wl of 32P 5P-
end-labelled primer D (5 pmol) and 1 U Taq polymerase in PCR reaction
buffer. The mixture was subjected to four further cycles of 94³C, 1 min,
61³C, 1 min and 72³C, 1 min, 72³C, 5 min and 4³C, 1 h. The beads
were removed by spinning brie£y and rinsed with 100 Wl ddH2O. The
supernatant was removed, precipitated with ethanol. Samples were re-
suspended in 5 Wl formamide loading buffer, denatured at 95³C for
3 min, cooled on ice and electrophoresed at 1500 V for 3 h in a
50 cmU21 cmU0.4 mm, 6% polyacrylamide sequencing gel (SequaGel
6; National Diagnostics, UK). The gel was dried and autoradiographed
(Kodak Hyper ¢lm, Amersham. UK).
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